Role of heme in brain functions: Dr. Jekyll or Mr. Hyde?

Heme Biology: The Secret Life of Heme in Regulating Diverse Biological Processes

Volumn , Issue , 2011, Pages 85-126

  Chernova, Tatyana ^a   Smith, Andrew G ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84970967292     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814287937_0005     Document Type: Chapter

References (144)

1. Ajioka RS, Phillips JD, Kushner JP. 2006. Biosynthesis of heme in mammals. Biochim Biophys Acta 1763: 723-736.
2. Nagaiah K, MacDonnell P, Guroff G. 1977. Induction of tyrosine hydroxlase synthesis in rat superior cervical ganglia in vitro by nerve growth factor and dexamethasone. Biochem Biophys Res Commun 75: 832-837.
3. Sassa S, Nagai T. 1996. The role of heme in gene expression. Int J Hematol 63: 167-178.
4. Badminton MN, Elder GH. 2005. Molecular mechanisms of dominant expression in porphyria. J Inherit Metab Dis 28: 277-286.
5. Whatley SD, Ducamp S, Gouya L, Grandchamp B, Beaumont C, Badminton MN, Elder GH, Holme SA, Anstey AV, Parker M, Corrigall AV, Meissner PN, Hift RJ, Marsden JT, Ma Y, Mieli-Vergani G, Deybach JC, Puy H. 2008. C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 83: 408-414.
6. Handschin C, Lin J, Rhee J, Peyer AK, Chin S, Wu PH, Meyer UA, Spiegelman BM. 2005. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-lalpha. Cell 122: 505-515.
7. Buerk DG, Saidel GM. 1977. A comparison of two nonclassical models for oxygen consumption in brain and liver tissue. Adv Exp Med Biol 94: 225-232.
8. Marks GS. 1985. Exposure to toxic agents: The heme biosynthetic pathway and hemoproteins as indicator. Crit Rev Toxicol 15: 151-179.
9. Smith AG, Elder GH. 2010. Complex gene-chemical interactions: Hepatic uroporphyria as a paradigm. Chem Res Toxicol 23: 712-723.
10. Moore MR, Goldberg A, Yeung-Laiwah AA. 1987. Lead effects on the heme biosynthetic pathway. Relationship to toxicity. Ann NY Acad Sci 514: 191-203.
11. Opler MG, Brown AS, Graziano J, Desai M, Zheng W, Schaefer C, Factor-Litvak P, Susser ES. 2004. Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. Environ Health Perspect 112: 548-552.
12. De Matteis F, Zetterlund P, Wetterberg L. 1981. Brain 5-aminolaevulinate synthase. Developmental aspects and evidence for regulatory role. Biochem J 196:811-817.
13. Tschudy DP, Hess RA, Frykholm BC. 1981. Inhibition of delta-aminolevulinic acid dehydrase by 4.6-dioxoheptanoic acid. J Biol Chem 256: 9915-9923.
14. Kang K, Anderson-Burham LA, Bloomer JR. 1987. Effect of succinylace-tone administration on brain heme metabolism and behavior in mice. Biochem Pharmacol 36: 3084-3086.
15. Paterniti JR, Jr.. Lin Cl, Beattie DS. 1978. Deltaaminolevulinic acid synthetase: Regulation of activity in various tissues of the aging rat. Arch Biochem Biophys 191: 792-797.
16. Litman DA, Correia MA. 1983. L-tryptophan: A common denominator of biochemical and neurological events of acute hepatic porphyria? Science 222: 1031-1033.
17. De Matteis F, Ray DE. 1982. Studied on cerebellar haem metabolism in the rat in vivo. J Neurochem 39: 551-556.
18. Ingi T, Chiang G, Ronnett GV. 1996. The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons. J Neurosci 16: 5621-5628.
19. Kumar S, Bandyopadhyay U. 2005. Free heme toxicity and its detoxification systems in human. Toxicol Lett 157: 175-188.
20. Ribo M, Grotta JC. 2006. Latest advances in intracerebral hemorrhage. Curr Neurol Neurosci Rep 6: 17-22.
21. Wang J, Dore S. 2007. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 27: 894-908.
22. Kaptain GJ, Lanzino G, Kassell NF. 2000. Subarachnoid haemorrhage: Epidemiology, risk factors, and treatment options. Drugs Aging 17: 183-199.
23. Hua Y, Xi G, Keep RF, Hoff JT. 2000. Complement activation in the brain after experimental intracerebral hemorrhage. J Neurosurg 92: 1016-1022.
24. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF. 2003. Heme and iron metabolism: Role in cerebral hemorrhage. J Cereb Blood Flow Metab 23: 629-652.
25. Umbreit J. 2007. Methemoglobin it’s not just blue: A concise review. Am J Hematol 82: 134-144.
26. Pohlman TH, Harlan JM. 2000. Adaptive responses of the endothelium to stress. J Surg Res 89: 85-119.
27. Arruda MA, Rossi AG, de Freitas MS, Barja-Fidalgo C, Graca-Souza AV. 2004. Heme inhibits human neutrophil apoptosis: Involvement of phospho-inositide 3-kinase. MAPK, and NF-kappaB. J Immunol 173: 2023-2030.
28. Goldstein L, Teng ZP, Zeserson E, Patel M, Regan RF. 2003. Hemin induces an iron-dependent, oxidative injury to human neuron-like cells. J Neurosci Res 73: 113-121.
29. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. 2001. Spontaneous intracerebral hemorrhage. N Engl J Med 344: 1450-1460.
30. Li RC, Saleem S, Zhen G, Cao W, Zhuang H, Lee J, Smith A, Altruda F, Tolosano E, Dore S. 2009. Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J Cereb Blood Flow Metab 29: 953-964.
31. Turner CP, Bergeron M, Matz P, Zegna A, Noble LJ, Panter SS, Sharp FR. 1998. Heme oxygenase-1 is induced in glia throughout brain by subarachnoid hemoglobin. J Cereb Blood Flow Metab 18: 257-273.
32. Matz PG, Weinstein PR, Sharp FR. 1997. Heme oxygenase-1 and heat shock protein 70 induction in glia and neurons throughout rat brain after experimental intracerebral hemorrhage. Neurosurgery 40: 152-160; discussion 60-62.
33. Aft RL, Mueller GC. 1983. Hemin-mediated DNA strand scission. J Biol Chem 258: 12069-12072.
34. Sassa S. 2004. Why heme needs to be degraded to iron, biliverdin IXalpha. and carbon monoxide? Antioxid Redox Signal 6: 819-824.
35. Clark JF, Loftspring M, Wurster WL, Beiler S, Beiler C, Wagner KR, Pyne-Geithman GJ. 2008. Bilirubin oxidation products, oxidative stress, and intracerebral hemorrhage. Acta Neurochir Suppl 105: 7-12.
36. Miller YI, Felikman Y, Shaklai N. 1996. Hemoglobin induced apolipoprotein B crosslinking in low-density lipoprotein peroxidation. Arch Biochem Biophys 326: 252-260.
37. Valko M, Morris H, Cronin MT. 2005. Metals, toxicity and oxidative stress. Curr Med Chem 12: 1161-1208.
38. Regan RF, Panter SS. 1996. Hemoglobin potentiates excitotoxic injury in cortical cell culture. J Neurotrauma 13: 223-231.
39. Xi G, Keep RF, Hoff JT. 1998. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg 89: 991-996.
40. Hua Y, Nakamura T, Keep RF, Wu J, Schallert T, Hoff JT, Xi G. 2006. Long-term effects of experimental intracerebral hemorrhage: The role of iron. J Neurosurg 104: 305-312.
41. Regan RF, Panter SS. 1993. Neurotoxicity of hemoglobin in cortical cell culture. Neurosci Lett 153: 219-222.
42. Letarte PB, Lieberman K, Nagatani K. Haworth RA, Odell GB, Duff TA. 1993. Hemin: Levels in experimental subarachnoid hematoma and effects on dissociated vascular smooth-muscle cells. J Neurosurg 79: 252-255.
43. Jaremko KM, Chen-Roetling J, Chen L, Regan RF. 2010. Accelerated hemolysis and neurotoxicity in neuron-glia-blood clot co-cultures. J Neurochem 114: 1063-1073.
44. Vecchione C, Frati A, Di Pardo A, Cifelli G, Carnevale D, Gentile MT, Carangi R, Landolfi A, Carullo P, Bettarini U, Antenucci G, Mascio G, Busceti CL, Notte A, Maffei A, Cantore GP, Lembo G. 2009. Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage. Hypertension 54: 150-156.
45. Sadradeh SM, Eaton JW. 1988. Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest 82: 1510-1515.
46. Haorah J, Ramirez SH, Schall K, Smith D, Pandya R, Persidsky Y. 2007. Oxidative stress activates protein tyrosine kinase and matrix metallopro-teinases leading to blood-brain barrier dysfunction. J Neurochem 101: 566-576.
47. Wrang J, Tsirka SE. 2005. Neuroprotection by inhibition of matrix metallo-proteinases in a mouse model of intracerebral haemorrhage. Brain 128: 1622-1633.
48. Katsu M, Niizuma K, Yoshioka H, Okami N, Sakata H, Chan PH. 2010. Hemoglobin-induced oxidative stress contributes to matrix metallopro-teinase activation and blood-brain barrier dysfunction m vivo. J Cereb Blood Flow Metab 30: 1939-1950.
49. Xue M, Fan Y, Liu S, Zygun DA, Demchuk A, Yong VW. 2009. Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage. Brain 132: 26-36.
50. Wrang X, Mori T, Sumii T, Lo EH. 2002. Hemoglobin-induced cytotoxicity in rat cerebral cortical neurons: Caspase activation and oxidative stress. Stroke 33: 1882-1888.
51. Burmester T, Weich B, Reinhardt S, Hankeln T. 2000. A vertebrate globin expressed in the brain. Nature 407: 520-523.
52. Herold S, Fago A, Weber RE, Dewilde S, Moens L. 2004. Reactivity studies of the Fe(III) and Fe(II)NO forms of human neuroglobin reveal a potential role against oxidative stress. J Biol Chem 279: 22841-22847.
53. Ogawa K, Sun J, Taketani S, Nakajima O, Nishitani C, Sassa S, Hayashi N, Yamamoto M, Shibahara S, Fujita II, Igarashi K. 2001. Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bachl. EMBO J 20: 2835-2843
54. Fago A, Hundahl C, Dewilde S, Gilany K, Moens L, Weber RE. 2004. Allosteric regulation and temperature dependence of oxygen binding in human neuroglobin and cytoglobin. Molecular mechanisms and physiological significance. J Biol Chem 279: 44417-44426
55. Bonding SH, Henty K, Dingley AJ, Brittain T. 2008. The binding of cytochrome c to neuroglobin: A docking and surface plasmon resonance study. Int J Biol Macromol 43: 295-299.
56. Sun Y, Jin K, Peel A, Mao XO, Xie L, Greenberg DA. 2003. Neuroglobin protects the brain from experimental stroke in vivo. Proc Natl Acad Sci USA 100: 3497-3500.
57. Li RC, Morris MW, Lee SK, Pouranfar F, Wang Y, Gozal D. 2008. Neuroglobin protects PC 12 cells against oxidative stress. Brain Res 1190: 159-166.
58. Reuben RC, Khanna PL, Gazitt Y, Breslow R, Rifkind RA, Marks PA. 1978. Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds. J Biol Chem 253: 4214-4218.
59. Li RC, Guo SZ, Lee SK, Gozal D. 2010. Neuroglobin protects neurons against oxidative stress in global ischemia. J Cereb Blood Flow Metab 30: 1874-1882.
60. Wakasugi K, Kitatsuji C, Morishima I. 2005. Possible neuroprotective mechanism of human neuroglobin. Ann N Y Acad Sci 1053: 220-230.
61. Schelshorn DW, Schneider A, Kuschinsky W, Weber D, Kruger C, Dittgen T, Burgers HF, Sabouri F, Gassier N, Bach A, Maurer MH. 2009. Expression of hemoglobin in rodent neurons. J Cereb Blood Flow Metab 29: 585-595.
62. Biagioli M, Pinto M, Cesselli D, Zaninello M, Lazarevic D, Roncaglia P, Simone R, Vlachouli C, Plessy C, Bertin N, Beltrami A, Kobayashi K, Gallo V, Santoro C, Ferrer I, Rivella S, Beltrami CA, Carninci P, Raviola E, Gustincich S. 2009. Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci USA 106: 15454-15459.
63. Nakamura A, Fujiwara S, Ishijima T, Okada S, Nakai Y, Matsumoto I, Misaka T, Abe K. 2010. Neuron differentiation-related genes are up-regulated in the hypothalamus of odorant-inhaling rats subjected to acute restraint stress. J Agric Food Chem 58: 7922-7929.
64. McCoubrey WK, Huang TJ, Maines MD. 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247: 725-732.
65. Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, Noguchi M. 2004. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336: 241-250.
66. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. 1993. Carbon monoxide: A putative neural messenger. Science 259: 381-384.
67. Maines MI. 2000. The heme oxygenase system and its functions in the brain. Cell Mol Biol (Noisy-le-grand) 46: 573-585.
68. Schipper HM, Song W, Zukor H, Hascalovici JR, Zeligman D. 2009. Heme oxygenase-1 and neurodegeneration: Expanding frontiers of engagement. J Neurochem 110: 469-485.
69. Takeda A, Perry G, Abraham NG, Dwyer BE, Kutty RK, Laitinen JT, Petersen RB, Smith MA. 2000. Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J Biol Chem 275: 5395-5399.
70. Cuadrado A, Rojo AI. 2008. Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections. Curr Pharm Des 14: 429-442.
71. Scapagnini G, Colombrita C, Amadio M, DAgata V, Arcelli E, Sapienza M, Quattrone A, Calabrese V. 2006. Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid Redox Signal 8: 395-403.
72. Sakoda E, Igarashi K, Sun J, Kurisu K, Tashiro S. 2008. Regulation of heme oxygenase-1 by transcription factor Bachl in the mouse brain. Neurosci Lett 440: 160-165.
73. Kannan M, Steinert JR, Forsythe ID, Smith AG, Chernova T. 2010. Mevastatin accelerates loss of synaptic proteins and neurite degeneration in aging cortical neurons in a heme-independent manner. Neurobiol Aging 31: 1543-1553.
74. Schipper HM, Gupta A, Szarek WA. 2009. Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD. Curr Alzheimer Res 6: 424-430.
75. Dore S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Cuastella D, Snyder SH. 1999. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci U S A 96: 2445-2450.
76. Regan RF, Kumar N, Gao F, Guo Y. 2002. Ferritin induction protects cortical astrocytes from heme-mediated oxidative injury. Neuroscience 113: 985-994.
77. Rogers B, Yakopson V, Teng ZP, Guo Y, Regan RF. 2003. Heme oxygenase-2 knockout neurons are less vulnerable to hemoglobin toxicity. Free Radic Biol Med 35: 872-881.
78. Chang EF, Wong RJ, Vreman HJ, Igarashi T, Galo E, Sharp FR, Stevenson DK, Noble-Haeusslein LJ. 2003. Heme oxygenase-2 protects against lipid peroxidation-mediated cell loss and impaired motor recovery after traumatic brain injury. J Neurosci 23: 3689-3696.
79. Ingi T, Cheng J, Ronnett GV. 1996. Carbon monoxide: An endogenous modulator of the nitric oxide-cyclic GMP signaling system. Neuron 16: 835-842.
80. Chen JJ, London IM. 1995. Regulation of protein synthesis by heme-regulated elF-2 alpha kinase. Trends Biochem Sci 20: 105-108.
81. Wang S, Publicover S, Gu Y. 2009. An oxygen-sensitive mechanism in regulation of epithelial sodium channel. Proc Natl Acad Sci USA 106: 2957-2962.
82. Tang XD, Xu R, Reynolds MF, Garcia ML, Heinemann SH, Hoshi T. 2003. Haem can bind to and inhibit mammalian calcium-dependent Slol BK channels. Nature 425: 531-535.
83. Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, Waitt GM, Parks DJ, Pearce KH, Wisely GB, Lazar MA. 2007. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science 318: 1786-1789.
84. Raghuram S, Stayrook KR, Huang P, Rogers PM, Nosie AK, McClure DB, Burris LL, Khorasanizadeh S, Burris TP, Rastinejad F. 2007. Identification of heme as the ligand for the orphan nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Strict Mol Biol 14: 1207-1213.
85. Faller M, Matsunaga M, Yin S, Loo JA, Guo F. 2007. Heme is involved in microR.NA processing. Nat Struct Mol Biol 14: 23-29.
86. Roberts AG, Elder GH. 2001. Alternative splicing and tissue-specific transcription of human and rodent ubiquitous 5-aminolevulinate synthase (ALASl) genes. Biochim Biophys Acta 1518: 95-105.
87. Meyer RJ, Gehlhaus M. 2010. A role for CYP in the drug-hormone crosstalk of the brain. Expert Opin Drug Metab Toxicol 6: 675-687.
88. Hamilton JW, Bement WJ, Sinclair PR, Sinclair JF, Alcedo JA, Wetterhahn KE. 1991. Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. Arch Biochem Biophys 289: 387-392.
89. Hayashi N, Terasawa M, Yamauchi K, Kikuchi G. 1980. Effects of hemin on the synthesis and intracellular translocation of delta-aminolevulinate synthase in the liver of rats treated with 3,5-dicarbethoxy-1.4-dihydrocollidine. J Biochem 88: 1537-1543.
90. Atamna H, Liu J, Ames BN. 2001. Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: Revelance to aging. J Biol Chem 276: 48410-48416.
91. Chernova T, Nicotera P, Smith AG. 2006. Heme deficiency is associated with senescence and causes suppression of N-methyl-D-aspartate receptor subunits expression in primary cortical neurons. Mol Pharmacol 69: 697-705.
92. Chernova T, Steinert JR, Guerin CJ, Nicotera P, Forsythe ID, Smith AG. 2007. Neurite degeneration induced by heme deficiency mediated via inhibition of NMD A receptor-dependent extracellular signal-regulated kinase 1/2 activation. J Neurosci 27: 8475-8485.
93. Sengupta A, Hon T, Zhang L. 2005. Heme deficiency suppresses the expression of key neuronal genes and causes neuronal cell death. Brain Res Mol Brain Res 137: 23-30.
94. Davies R, Schuurman A, Barker CR, Clothier B, Chernova T, Higginson FM, Judah DJ, Dinsdale D, Edwards RE, Greaves P, Gant TW, Smith AG. 2005. Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool. Am J Pathol 166: 1041-1053.
95. Tutois S, Montagutelli X, Da Silva V, Jouault H, Rouyer-Fessard P, Leroy-Viard K, Guenet JL, Nordmann Y, Beuzard Y, Deybach JC. 1991. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease. J Clin Invest 88: 1730-1736.
96. Wilks A, Ortiz de Montellano PR, Sun J, Loehr TM. 1996. Heme oxygenase (HO-1): His-132 stabilizes a distal water ligand and assists catalysis. Biochemistry 35: 930-936.
97. Zhu Y HT, Ye W, Zhang L. 2002. Heme deficiency interferes with the Ras-mitogen-activated protein kinase signaling pathway and expression of a subset of neuronal genes. Cell Growth Differ. 13: 431-439.
98. Hardingham GE. 2006. Pro-survival signalling from the NMD A receptor. Biochem Soc Trans 34: 936-938.
99. Ishii DN, Maniatis GM. 1978. Haemin promotes rapid neurite outgrow'th in cultured mouse neuroblastoma cells. Nature 274: 372-374.
100. Greengard P. 1978. Phosphorylated proteins as physiological effectors. Science 199: 146-152.
101. Shinjyo N, Kita K. 2006. Up-regulation of heme biosynthesis during differentiation of Neuro2a cells. J Biochem 139: 373-381.
102. Shinjyo N, Kita K. 2007. Relationship between reactive oxygen species and heme metabolism during the differentiation of Neuro2a cells. Biochem Biophys Res Commun 358: 130-135.
103. Atamna H, Killilea DW, Killilea AN, Ames BN. 2002. Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc Natl Acad Sci USA 99: 14807-14812.
104. Kimura I, Yoshioka M, Konishi M. Miyake A, Itoh N. 2005. Neudesin, a novel secreted protein with a unique primary structure and neurotrophic activity. J Neurosci Res 79: 287-294.
105. Kimura I, Nakayama Y, Yamauchi H, Konishi M, Miyake A, Mori M, Ohta M, Itoh N, Fujimoto M. 2008. Neurotrophic activity of neudesin. a novel extracellular heme-binding protein, is dependent on the binding of heme to its cytochrome b5-like heme/steroid-binding domain. J Biol Chem 283: 4323-4331.
106. Kimura I, Nakayama Y, Konishi M, Kobayashi T, Mori M, Ito M, Hirasawa A, Tsujimoto G, Ohta M, Itoh N, Fujimoto M. 2010. Neuferricin, a novel extracellular heme-binding protein, promotes neurogenesis. J Neurochem 112: 1156-1167.
107. Rodgers KR. 1999. Heme-based sensors in biological systems. Curr Opin Chem Biol 3: 158-167.
108. Gilles-Gonzalez MA, Gonzalez G. 2005. Heme-based sensors: Defining characteristics, recent developments, and regulatory hypotheses. J Inorg Biochem 99: 1-22.
109. Dioum EM, Rutter J, Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA, McKnight SL. 2002. NPAS2: A gas-responsive transcription factor. Science 298: 2385-2387.
110. Boehning D, Snyder SH. 2002. Circadian rhythms. Carbon monoxide and clocks. Science 298: 2339-2340.
111. Boehning D, Snyder SH. 2003. Novel neural modulators. Annu Rev Neurosci 26: 105-131.
112. Bitar MS, Shapiro BH. 1987. Aberration of heme and hemoprotein in aged female rats. Mech Ageing Dev 38: 189-197.
113. Meyer RP, Podvinec M, Meyer UA. 2002. Cytochrome P450 CYP1A1 accumulates in the cytosol of kidney and brain and is activated by heme. Mol Pharmacol 62: 1061-1067.
114. Correia MA, Meyer UA. 1975. Apocytochrome P-450: Reconstitution of functional cytochrome with hemin in vitro. Proc Natl Acad Sci USA 72: 400-404.
115. Podvinec M, Handschin C, looser R, Meyer UA. 2004. Identification of the xenosensors regulating human 5-aminolevulinate synthase. Proc Natl Acad Sci U S A 101: 9127-9132.
116. Fraser DJ, Zumsteg A, Meyer UA. 2003. Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene. J Biol Chem 278: 39392-39401.
117. Lin JH, Lu AY. 2001. Interindividual variability in inhibition and induction of cytochrome P450 enzymes. Annu Rev Pharmacol Toxicol 41: 535-567.
118. Miksys S, Tyndale RF. 2004. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev 36: 313-333.
119. Siegle I, Fritz P, Eckhardt K, Zanger UM, Eichelbaum M. 2001. Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. Pharmacogenetics 11: 237-245.
120. Gervasini G, Carrillo JA, Benitez J. 2004. Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: Modulation by endogenous compounds. Clin Pharmacokinet 43: 693-706.
121. Kennerfalk A, Ruigomez A, Wallander MA, Wilhelmsen L, Johansson S. 2002. Geriatric drug therapy and healthcare utilization in the United kingdom..4nn Pharmacother 36: 797-803.
122. Meyer RP, Lindberg RL, Hoffmann F, Meyer UA. 2005. Cytosolic persistence of mouse brain CYPlAl in chronic heme deficiency. Biol Chem 386: 1157-1164.
123. Yau JL, Noble J, Graham M, Seckl JR. 2006. Central administration of a cytochrome P450-7B product 7 alpha-hydroxypregnenolone improves spatial memory retention in cognitively impaired aged rats. J Neurosci 26: 11034-11040.
124. Rose KA, Stapleton G, Dott K, Kieny MP, Best R, Schwarz M, Russell DW, Bjorkhem I, Seckl J, Lathe R. 1997. Cyp7b. a novel brain cytochrome P450. catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandro sterone and 7alpha-hydroxy pregnenolone. Proc Natl Acad Sci USA 94: 4925-4930.
125. Magnusson KR, Nelson SE, Young AB. 2002. Age-related changes in the protein expression of subunits of the NMDA receptor. Brain Res Mol Brain Res 99: 40-45.
126. Raff MC, Whitmore AV, Finn JT. 2002. Axonal self-destruction and neu-rodegeneration. Science 296: 868-871.
127. Subbarao KV, Richardson JS. 1990. Iron-dependent peroxidation of rat brain: a regional study. J Neurosci Res 26: 224-232.
128. Pamplona R, Dalfo E, Ayala V, Bellmunt MJ, Prat J, Ferrer I, Portero-Otin M. 2005. Proteins in human brain cortex are modified by oxidation, glycoxida-tion, and lipoxidation. Effects of Alzheimer disease and identification of lipoxidation targets. J Biol Chem 280: 21522-21530.
129. Altamura S, Muckenthaler MU. 2009. Iron toxicity in diseases of aging: Alzheimer’s disease, Parkinson’s disease and atherosclerosis. J Alzheimers Dis 16: 879-895.
130. Atamna H, Frey WH, Ko N. 2009. Human and rodent amyloid-beta peptides differentially bind heme: Relevance to the human susceptibility to Alzheimer’s disease. Arch Biochem Biophys 487: 59-65.
131. Atamna H, Frey WH. 2004. A role for heme in Alzheimer’s disease: heme binds amyloid beta and has altered metabolism. Proc Natl Acad Sci USA 101: 11153-11158.
132. Scheuermann S, Hambsch B, Hesse L, Stumm J, Schmidt C, Beher D, Bayer TA, Beyreuther K, Multhaup G. 2001. Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer’s disease. J Biol Chem 276: 33923-33929.
133. Howlett D, Cutler P, Heales S, Camilleri P. 1997. Hemin and related porphyrins inhibit beta-amyloid aggregation. FEBS Lett 417: 249-251.
134. Gatta LB, Vitali M, Verardi R, Arosio P, Finazzi D. 2009. Inhibition of heme synthesis alters Amyloid Precursor Protein processing. J Neural Transm 116: 79-88.
135. Dwyer BE, Smith MA, Richardson SL, Perry G, Zhu X. 2009. Down-regulation of aminolevulinate synthase, the rate-limiting enzyme for heme biosynthesis in Alzheimer’s disease. Neurosci Lett 160: 180-184.
136. Zheng B, Albrecht U, Kaasik K, Sage M, Lu W, Vaishnav S, Li Q, Sun ZS, Eichele G, Bradley A, Lee CC. 2001. Nonredundant roles of the mPerl and mPer2 genes in the mammalian circadian clock. Cell 105: 683-694.
137. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M, Schultz PG, Kay SA, Takahashi JS, Hogenesch JB. 2002. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109: 307-320.
138. Akhtar RA, Reddy AB, Maywood ES, Clayton JD, King VM, Smith AG, Gant TW, Hastings MH, Kyriacou CP. 2002. Circadian cycling of the mouse liver transcriptome, as revealed by cDNA microarray, is driven by the suprachiasmatic nucleus. Curr Biol 12: 540-550.
139. Kaasik K, Lee CC. 2004. Reciprocal regulation of haem biosynthesis and the circadian clock in mammals. Nature 430: 467-471.
140. Koudo R, Kurokawa II, Sato E, Igarashi J, Uchida T, Sagami I, Kitagawa T, Shimizu T. 2005. Spectroscopic characterization of the isolated heme-bound PAS-B domain of neuronal PAS domain protein 2 associated with circadian rhythms. Febs J 272: 4153-4162.
141. Mukaiyama Y, Uchida T, Sato E, Sasaki A, Sato Y, Igarashi J, Kurokawa H, Sagami I, Kitagawa T, Shimizu T. 2006. Spectroscopic and DNA-binding characterization of the isolated heme-bound basic helix-loop-helix-PAS-A domain of neuronal PAS protein 2 (NPAS2), a transcription activator protein associated with circadian rhythms. Febs J 273: 2528-2539.
142. Kitanishi K, Igarashi J, Hayasaka K, Hikage N, Saiful I, Yamauchi S, Uchida T, Ishimori K, Shimizu T. 2008. Heme-binding characteristics of the isolated PAS-A domain of mouse Per'2, a transcriptional regulatory factor associated with circadian rhythms. Biochemistry 47: 6157-6168.
143. Yang J, Kim KD, Lucas A, Drahos KE, Santos CS, Mury SP, Capelluto DG, Finkielstein CV. 2008. A novel heme-regulatory motif mediates heme-dependent degradation of the circadian factor period 2. Mol Cell Biol 28: 4697-4711.
144. Airola MV, Du J, Dawson JH, Crane BR. 2010. Heme binding to the mammalian circadian clock protein period 2 is nonspecific. Biochemistry 49: 4327-4338.